Fagron NV

    Jurisdiction
    Belgium
    LEI
    549300TRKRUFK2RRG779
    ISIN
    BE0003874915 (FAGR.BR)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €1.63B
    Gross margin
    27.5%
    EBIT
    €240.34M
    EBIT margin
    14.7%
    Net income
    €151.10M
    Net margin
    9.2%

    Statement period: - (published )

    Dividends

    Last dividend amount
    €0.35
    Ex date
    Payment date
    Dividend payout ratio
    26.0%

    Earnings Calls

    Latest earnings call: August 6, 2023

    Add to watchlist

    Notifications